Owens & Minor says it is in the final stages of selling its Products & Healthcare Services segment, says CEO Ed Pesicka.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

UBS analyst Kevin Caliendo lowered the firm’s price target on Owens & Minor to $7 from $13 and keeps a Buy rating on the shares. Owens & Minor’s ...

Owens & Minor (OMI) has disclosed a new risk, in the Corporate Activity and Growth category. Owens & Minor faces significant business risks with ...

Owens & Minor, Inc. faces financial distress with a 70% stock drop, weak margins, and strategic missteps. Click here to find out why OMI stock is a Hold.

Owens & Minor, Inc. OMI will release earnings results for the second quarter before the opening bell on Monday, Aug. 11.

Owens & Minor's canceled Rotech deal eases financial risks. Click to read a full investment analysis of OMI stock and why its ...

The company’s adjusted EBITDA from continuing operations increased to $96.6 million in the second quarter, compared to $91.1 million in the prior-year period. Owens & Minor has classified its Products ...

Shares of Owen & Minor fell after the company posted a wider loss and lower-than-expected revenue in the second quarter. Shares fell almost 32% to $4.83 Monday morning. The stock is down 64% year to ...

(OMI) on Monday reported a loss of $869.1 million in its second quarter. The Glen Allen, Virginia-based company said it had a loss ...

Shares of medical supply and logistics company Owens & Minor (NYSE:OMI) fell 3.5% in the afternoon session after the broader healthcare sector traded lower as industry heavyweight UnitedHealth Group ...

Shares of medical supply and logistics company Owens & Minor (NYSE:OMI) fell 3.5% in the afternoon session after the broader healthcare sector traded lower as industry heavyweight UnitedHealth Group ...